4//SEC Filing
Wolf Myles 4
Accession 0001562180-20-002937
CIK 0001517022other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 8:31 AM ET
Size
5.4 KB
Accession
0001562180-20-002937
Insider Transaction Report
Form 4
Wolf Myles
Director
Transactions
- Award
Stock Option (Right to buy)
2020-04-06+80,200→ 80,200 totalExercise: $7.09Exp: 2030-04-06→ Common Stock (80,200 underlying)
Footnotes (1)
- [F1]The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001808317
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 8:31 AM ET
- Size
- 5.4 KB